CLINICAL_TRIALS
trial_result
· 2025-05-29
Clinical Trial Update: A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral Sclerosis [Phase 2]
Summary
A 6-month extension study to assess the long-term safety of Engensis in amyotrophic lateral sclerosis has completed, with results posted on 2025-05-29.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Helixmith Co., Ltd. | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2025-05-29